Results 121 to 130 of about 9,981 (208)

Targeting Microglial HDAC3 Enhances Aβ Clearance and Neuroprotection in APP/PS1 Mice: A Ketogenic Diet‐Driven Strategy

Food Frontiers, Volume 7, Issue 5, September 2026.
Ketogenic diet (KD) confers neuroprotection in Alzheimer's disease by inhibiting microglial HDAC3. This simultaneously enhances Aβ clearance via TREM2‐mediated phagocytosis and AMPK–ULK1‐driven autophagy, while suppressing NLRP3 inflammasome activation, ultimately attenuating Aβ/tau pathology and neuronal damage. ABSTRACT Growing evidence suggests that
Mingxiao Zheng, Gabriele Loers, Shengnan Lin, Hans‐Christian Siebert, Qingpeng Wang, Ruiyan Zhang, Xuexing Zheng, Ning Zhang   +7 more
wiley   +1 more source

Case report: Resolution of malignant canine mast cell tumor using ketogenic metabolic therapy alone. [PDF]

Front Nutr, 2023
Seyfried TN, Mukherjee P, Lee DC, Ta L, Nations L.   +4 more
europepmc   +1 more source

Conjugated Linoleic Acid‐Enriched Fermented Dairy Modulates Microbiota and Metabolites to Alleviate MASLD: Insights From Multi‐Omics and Causal Mediation Analysis

Food Frontiers, Volume 7, Issue 5, September 2026.
In a 120‐day randomized trial, CLA‐enriched fermented dairy remodeled the gut microbiota and rewired host metabolic pathways in patients with MASLD. These changes were accompanied by reductions in ALT, total cholesterol, creatinine, and hs‐CRP, supporting a microbiota‐mediated dietary strategy for metabolic and liver health.
Fei Mi, Yanjiao Wang, Jia Xiong, Yiyuan Ma, Hongmei Pan, Jianzhong Yin, Yunmei Chai, Yao Wang, Xin Xu, Ai Zhang, Qingwen Ma, Hui Wang, Dongbai Liu, Shaoxiong Wu   +13 more
wiley   +1 more source

Additional file 3 of Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma

Supplementary Material 3.
Duraj, Tomás, Kalamian, Miriam, Zuccoli, Giulio, Maroon, Joseph C., D’Agostino, Dominic P., Scheck, Adrienne C., Poff, Angela, Winter, Sebastian F., Hu, Jethro, Klement, Rainer J., Hickson, Alicia, Lee, Derek C., Cooper, Isabella, Kofler, Barbara, Schwartz, Kenneth A., Phillips, Matthew C. L., Champ, Colin E., Zupec-Kania, Beth, Tan-Shalaby, Jocelyn, Serfaty, Fabiano M., Omene, Egiroh, Arismendi-Morillo, Gabriel, Kiebish, Michael, Cheng, Richard, El-Sakka, Ahmed M., Pflueger, Axel, Mathews, Edward H., Worden, Donese, Shi, Hanping, Cincione, Raffaele Ivan, Spinosa, Jean Pierre, Slocum, Abdul Kadir, Iyikesici, Mehmet Salih, Yanagisawa, Atsuo, Pilkington, Geoffrey J., Chaffee, Anthony, Abdel-Hadi, Wafaa, Elsamman, Amr K., Klein, Pavel, Hagihara, Keisuke, Clemens, Zsófia, Yu, George W., Evangeliou, Athanasios E., Nathan, Janak K., Smith, Kris, Fortin, David, Dietrich, Jorg, Mukherjee, Purna, Seyfried, Thomas N.   +48 more
openaire   +1 more source

High‐Protein Diet Ameliorates Cardiomyopathy in a Cardiac‐Specific AGL Knockout Mouse Model: Association With Upregulated Hepatic Gluconeogenesis

Journal of Inherited Metabolic Disease, Volume 49, Issue 5, September 2026.
ABSTRACT Glycogen storage disease type IIIa (GSDIIIa) causes progressive cardiomyopathy, and current high‐fat dietary strategies lack consensus regarding long‐term cardiovascular safety. We evaluated the efficacy and safety of high‐protein versus high‐fat diets in a novel cardiac‐specific AGL knockout (CKO; AGLflox/flox/MHC‐Cre) mouse model to ...
Caiqi Du, Hao Fu, Tingting Yu, Sisi Cao, Haotian Zhang, Boda Wei, Cai Zhang, Juan Ye, Wenjun Long, Xiaoping Luo, Yan Liang   +10 more
wiley   +1 more source

Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of IDH1-Mutant Glioblastoma: An 80-Month Follow-Up Case Report. [PDF]

Front Nutr, 2021
Seyfried TN, Shivane AG, Kalamian M, Maroon JC, Mukherjee P, Zuccoli G.   +5 more
europepmc   +1 more source

From Common Pathway to Divergent Diseases: Metabolic Aspects of Inborn Errors of CoA Biosynthesis

Journal of Inherited Metabolic Disease, Volume 49, Issue 5, September 2026.
ABSTRACT Coenzyme A (CoA) biosynthesis is a conserved, dynamically regulated pathway essential for mitochondrial energy production, fatty acid oxidation, lipid biosynthesis and protein acylation. Biallelic variants in PANK2, PPCS, PPCDC, and COASY cause rare inborn errors of CoA biosynthesis, associated with markedly different clinical phenotypes ...
Ivano Di Meo, Yair Anikster, Valeria Tiranti, Arcangela Iuso   +3 more
wiley   +1 more source

Glucose Transporter Deficiency Syndrome Type 1 (Glut1‐DS): New Insights From a Brazilian Cohort of Patients

JIMD Reports, Volume 67, Issue 5, September 2026.
ABSTRACT Glucose transporter deficiency syndrome type 1 (Glut1‐DS) is a rare neurometabolic disorder caused by pathogenic variants in SLC2A1, characterized by epilepsy, neurodevelopmental delay, movement disorders, dysarthria, intellectual disability, and postnatal microcephaly.
Lívia Maria Ferreira Sobrinho, Juliana Cristine Fontana, Claudia F. Lorea, Helio van der Linden Júnior, Andréa C. S. Leite, Rayana Elias Maia, Lilia Farret, Carolina F. Moura de Souza, Soraia Poloni, Fabiano O. Poswar, Ida Vanessa D. Schwartz, Fernanda Sperb‐Ludwig   +11 more
wiley   +1 more source

Medium Chain Acyl‐CoA Dehydrogenase Deficiency; an Unexpected Cause of Neonatal Ketoacidosis

JIMD Reports, Volume 67, Issue 5, September 2026.
ABSTRACT Medium‐chain acyl‐CoA dehydrogenase deficiency (MCADD) classically presents with hypoketotic hypoglycaemia; however, this presentation is now rare following the introduction of newborn screening. While children with MCADD may produce some ketones, severe ketoacidosis has not been previously described.
Nazreen Kamarus Jaman, Isaac Bernhardt, Sophie Ward, Freya Hassall, James Nurse, Hugh Lemonde, R. Neil Dalton, Michael Champion   +7 more
wiley   +1 more source

The Six Pillars of Lifestyle Medicine in MASLD: An Evidence‐Based Guide

Liver International Communications, Volume 7, Issue 3, September 2026.
ABSTRACT Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide and is projected to affect more than 40% of adults by 2050. Although pharmacologic therapies are emerging, lifestyle modification remains the foundation of management.
Jigyasa Sharma, Kathleen Viveiros
wiley   +1 more source